欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号EE/H/0280/001
药品名称LERCANIDIPINE ACTAVIS 10MG
活性成分
    • lercanidipine hydrochloride 10.0 mg
剂型Film-coated tablet
上市许可持有人Splitting from DK/H/1491/001-002/DC to EE/H/280/001-002/DC Teva B.V. Swensweg 5 2031 GA Haarlem Netherlands
参考成员国 - 产品名称Estonia (EE)
LERCANIDIPINE ACTAVIS 10MG
互认成员国 - 产品名称
    • Poland (PL)
      Lecalpin
    • Latvia (LV)
      Lercanidipin Actavis 10 mg apvalkotās tabletes
    • Lithuania (LT)
      Lercanidipin Actavis 10 mg plėvele dengtos
    • Hungary (HU)
      LECALPIN 10 mg filmtabletta
    • Bulgaria (BG)
      Lecalpin
    • Slovenia (SI)
许可日期2018/07/03
最近更新日期2023/08/31
药物ATC编码
    • C08CA13 lercanidipine
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:[not specified]
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase